FASEB BioAdvances

Scope & Guideline

Pioneering Discoveries in Physiology and Genetics

Introduction

Immerse yourself in the scholarly insights of FASEB BioAdvances with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationFASEB BIOADV / FASEB Bioadv.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

FASEB BioAdvances publishes research that spans a wide array of topics within the biological and biomedical sciences, emphasizing innovative methodologies and interdisciplinary approaches.
  1. Molecular and Cellular Biology:
    Research focusing on the molecular mechanisms underlying cellular processes, including gene expression, protein interactions, and cellular signaling pathways.
  2. Translational Medicine:
    Studies aimed at bridging basic research and clinical applications, particularly in understanding disease mechanisms and developing new therapeutic strategies.
  3. Microbiome and Immunology:
    Investigations into the role of the microbiome in health and disease, alongside studies on immune responses and mechanisms of immune evasion.
  4. Neuroscience and Neurology:
    Research examining neural mechanisms, neurodegenerative diseases, and the interaction between the nervous system and other body systems.
  5. Cancer Biology:
    Studies exploring the molecular and genetic basis of cancer, including tumor microenvironment interactions and potential therapeutic targets.
  6. Regenerative Medicine and Stem Cell Research:
    Research focusing on the potential of stem cells to repair or replace damaged tissues, including insights into developmental biology.
  7. Environmental and Lifestyle Factors:
    Research that investigates how environmental factors and lifestyle choices impact health, disease progression, and treatment outcomes.
Recent publications in FASEB BioAdvances highlight several trending and emerging themes that reflect the evolving landscape of biomedical research.
  1. Omics Technologies:
    There is a significant increase in the application of advanced omics technologies, such as transcriptomics and metabolomics, to understand complex biological systems and disease mechanisms.
  2. Microbiome Research:
    Research focusing on the gut microbiome and its implications for autoimmune diseases, metabolism, and overall health is gaining traction, highlighting the microbiome's critical role in human physiology.
  3. Cellular and Molecular Imaging:
    Emerging techniques in cellular and molecular imaging are being utilized to visualize and understand dynamic processes in live cells and tissues, enhancing our understanding of biological functions.
  4. Gene Editing and CRISPR Technologies:
    The use of gene editing technologies, particularly CRISPR, is increasingly prevalent, with studies exploring their applications in therapeutic contexts and functional genomics.
  5. Environmental and Societal Impacts on Health:
    Research addressing how environmental factors, lifestyle choices, and social determinants affect health outcomes is becoming more prominent, reflecting a holistic view of health.
  6. Extracellular Vesicles and Intercellular Communication:
    There is a growing focus on extracellular vesicles as key players in intercellular communication and their roles in disease progression and therapy, highlighting their potential as biomarkers and therapeutic targets.

Declining or Waning

While FASEB BioAdvances continues to cover a wide range of biomedical topics, certain themes appear to be losing prominence in recent publications.
  1. Traditional Pharmacology:
    Research focused solely on classical pharmacological approaches is becoming less prevalent, as the journal shifts towards more integrative and systems-based approaches.
  2. Basic Animal Models:
    Studies relying exclusively on traditional animal models without translational relevance are declining, as there is a growing emphasis on human-relevant models and methodologies.
  3. Non-interactive Educational Research:
    Papers focused on basic educational methods without interactive elements or engagement strategies are waning, indicating a shift towards more dynamic and participatory educational approaches.
  4. Single Facet Studies:
    Research that examines a single variable or factor in isolation is decreasing, as the trend moves towards more comprehensive studies that consider multiple interacting factors.

Similar Journals

FOLIA BIOLOGICA

Bridging Theory and Practice in Biology
Publisher: CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINEISSN: 0015-5500Frequency: 6 issues/year

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.

CELL RESEARCH

Pioneering Research for a Healthier Tomorrow
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

Journal of Translational Medicine

Bridging Discovery and Healing.
Publisher: BMCISSN: Frequency: 1 issue/year

Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.

DNA AND CELL BIOLOGY

Illuminating the Path of Cellular Advancements
Publisher: MARY ANN LIEBERT, INCISSN: 1044-5498Frequency: 12 issues/year

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

Cell Death & Disease

Leading the charge in transformative biomedical discoveries.
Publisher: SPRINGERNATUREISSN: 2041-4889Frequency: 1 issue/year

Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.

BMC Molecular and Cell Biology

Advancing the frontiers of molecular and cell biology.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

Cell and Bioscience

Empowering Knowledge Sharing in Molecular Biology
Publisher: BMCISSN: Frequency: 1 issue/year

Cell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.

MOLECULAR AND CELLULAR BIOLOGY

Exploring the Depths of Molecular Complexity
Publisher: TAYLOR & FRANCIS INCISSN: 0270-7306Frequency: 24 issues/year

MOLECULAR AND CELLULAR BIOLOGY, published by TAYLOR & FRANCIS INC, stands as a preeminent platform for researchers, professionals, and students engaged in the dynamic field of molecular and cellular biology. Established in 1981 and ongoing into 2024, the journal features cutting-edge research that spans across vital sub-disciplines, garnering a strong impact in its contributions to the scientific community. With an impressive Q2 ranking in Cell Biology and Q1 ranking in Molecular Biology for 2023, it consistently publishes high-quality articles that reflect the latest advancements and discoveries within the field. The journal is particularly well-regarded for its rigorous peer-review process and commitment to scientific excellence, making it an invaluable resource for those seeking to deepen their understanding of molecular mechanisms and cellular processes. Although not open access, the journal offers diverse access options for researchers to reach the latest findings. By maintaining a strong focus on biochemistry, genetics, and molecular biology, MOLECULAR AND CELLULAR BIOLOGY remains essential reading for anyone looking to contribute to or stay informed about significant developments within this pivotal area of study.

CELLULAR AND MOLECULAR LIFE SCIENCES

Advancing the Frontiers of Cellular and Molecular Discovery
Publisher: SPRINGER BASEL AGISSN: 1420-682XFrequency: 24 issues/year

CELLULAR AND MOLECULAR LIFE SCIENCES, published by SPRINGER BASEL AG, stands as a premier journal dedicated to advancing the field of cellular and molecular biology. With an impressive 2023 impact factor reflected in its Q1 rankings across key categories—including Cell Biology, Molecular Biology, and Pharmacology—it serves as a critical platform for researchers aiming to disseminate high-quality findings in these dynamic fields. Operated under an open access framework, the journal allows broader accessibility to groundbreaking research, fostering collaboration amongst scientists globally. Based in Switzerland, CELLULAR AND MOLECULAR LIFE SCIENCES has been at the forefront of scientific publishing since 1952, adapting to contemporary scientific challenges and trends, ultimately shaping the future of life sciences.

BMB Reports

Unlocking Knowledge for a Healthier Tomorrow
Publisher: KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGYISSN: 1976-6696Frequency: 12 issues/year

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.